SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-050669
Filing Date
2024-02-28
Accepted
2024-02-28 16:10:14
Documents
6
Effectiveness Date
2024-02-28

Document Format Files

Seq Description Document Type Size
1 S-8 d772361ds8.htm S-8 60490
2 EX-5.1 d772361dex51.htm EX-5.1 10346
3 EX-23.2 d772361dex232.htm EX-23.2 3509
4 EX-FILING FEES d772361dexfilingfees.htm EX-FILING FEES 38352
5 GRAPHIC g772361g0228001858091.jpg GRAPHIC 2246
6 GRAPHIC g772361page01.jpg GRAPHIC 8624
  Complete submission text file 0001193125-24-050669.txt   129392
Mailing Address 221 CRESCENT STREET BLDG. 17, SUITE 401 WALTHAM MA 02453
Business Address 221 CRESCENT STREET BLDG. 17, SUITE 401 WALTHAM MA 02453 617.272.4600
Viridian Therapeutics, Inc.\DE (Filer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-277453 | Film No.: 24695420
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)